0.2806
Precedente Chiudi:
$0.2927
Aprire:
$0.28
Volume 24 ore:
682.35K
Relative Volume:
1.83
Capitalizzazione di mercato:
$11.59M
Reddito:
$7.10M
Utile/perdita netta:
$-39.43M
Rapporto P/E:
-0.2985
EPS:
-0.94
Flusso di cassa netto:
$-46.50M
1 W Prestazione:
-4.91%
1M Prestazione:
-21.47%
6M Prestazione:
-38.45%
1 anno Prestazione:
-66.57%
Spruce Biosciences Inc Stock (SPRB) Company Profile
Nome
Spruce Biosciences Inc
Settore
Industria
Telefono
(415) 655-4168
Indirizzo
611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO
Confronta SPRB con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
SPRB
Spruce Biosciences Inc
|
0.2806 | 11.59M | 7.10M | -39.43M | -46.50M | -0.94 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Spruce Biosciences Inc Stock (SPRB) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-11 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
2024-12-11 | Downgrade | Oppenheimer | Outperform → Perform |
2024-03-14 | Downgrade | Guggenheim | Buy → Neutral |
2024-03-14 | Downgrade | H.C. Wainwright | Buy → Neutral |
2024-03-14 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
2024-03-14 | Downgrade | Leerink Partners | Outperform → Market Perform |
2024-03-14 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2024-02-21 | Iniziato | Guggenheim | Buy |
2021-12-17 | Iniziato | Oppenheimer | Outperform |
2021-12-10 | Iniziato | The Benchmark Company | Speculative Buy |
2021-11-16 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
2021-07-19 | Iniziato | H.C. Wainwright | Buy |
2021-04-26 | Ripresa | Credit Suisse | Outperform |
2020-11-03 | Iniziato | Cowen | Outperform |
2020-11-03 | Iniziato | Credit Suisse | Outperform |
2020-11-03 | Iniziato | RBC Capital Mkts | Outperform |
2020-11-03 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Spruce Biosciences Inc Borsa (SPRB) Ultime notizie
Layoff Tracker: Relay Will Cut 70 Employees, Affecting Research Budget by 75% - BioSpace
Spruce Biosciences reports delayed annual filing By Investing.com - Investing.com South Africa
Spruce Biosciences reports delayed annual filing - Investing.com
Spruce Biosciences Delays Annual Report Filing - TipRanks
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Spruce Biosciences stock hits 52-week low at $0.32 - Investing.com
In-Depth Analysis Of The Global Congenital Adrenal Hyperplasia Market: Key Drivers, Trends, Growth Opportun... - WhaTech
SPRUCE BIOSCIENCES INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
Invivyd, Inc. (IVVD) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Analysts Set Spruce Biosciences, Inc. (NASDAQ:SPRB) PT at $2.38 - Defense World
SPRB Stock Touches 52-Week Low at $0.34 Amid Steep Decline - Investing.com India
Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Spruce Biosciences (SPRB) to Release Quarterly Earnings on Wednesday - Defense World
Harbour Biomed newco HBM Alpha pens $395M hyperplasia drug deal - BioWorld Online
SPRB stock touches 52-week low at $0.34 amid sharp annual decline - Investing.com
Short Interest in Kingsoft Co. Limited (OTCMKTS:KSFTF) Increases By 79.4% - Defense World
Archer-Daniels-Midland Company (NYSE:ADM) Receives Consensus Rating of “Reduce” from Brokerages - Defense World
Traws Pharma, Inc. (NASDAQ:TRAW) Short Interest Update - Defense World
Spruce Biosciences, Inc. (NASDAQ:SPRB) Short Interest Up 81.4% in February - Defense World
SPRB stock touches 52-week low at $0.34 amid sharp annual decline By Investing.com - Investing.com South Africa
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
Spruce Biosciences, Inc. (SPRB) Reports Q2 Loss, Tops Revenue Estimates - MSN
NeoGenomics (NEO) Tops Q4 Earnings Estimates - Yahoo Finance
The Prothena Corporation plc (PRTA) had a good session last reading, didn’t it? - US Post News
Element Solutions Inc (NYSE:ESI) Receives $30.14 Consensus Price Target from Analysts - Defense World
Alamos Gold Inc. (TSE:AGI) Receives C$28.78 Average Target Price from Brokerages - Defense World
Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives $3.90 Consensus Target Price from Analysts - Defense World
Spruce Biosciences Inc [SPRB] Investment Appeal on the Rise - Knox Daily
Spruce Biosciences Inc (NASDAQ: SPRB) Stock Has Gained 4.05% Over The Month – Is There Room For Growth? - Marketing Sentinel
Should You Expect Akero Therapeutics Inc (NASDAQ:AKRO) To Recover From Its 70.02% Gain From Highs? - Marketing Sentinel
Five Point Holdings LLC (NYSE: FPH): Can The Stock Still Lose Despite An 54.23% YTD Gain? - Marketing Sentinel
Why you might not want to use AI to spruce up your job application - Yahoo
Spruce Biosciences Inc (SPRB) Stock Price and Analyst Predictions - The News Heater
Spruce Biosciences Inc (NASDAQ:SPRB) stock: You might be surprised - US Post News
Examining OppFi Inc (OPFI) stock is warranted - US Post News
(PDF) Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials - ResearchGate
Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives $3.90 Consensus Target Price from Brokerages - Defense World
Spruce Biosciences Inc Azioni (SPRB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):